Parkinson's disease

International Review of Neurobiology

Volumn 53, Issue , 2002, Pages 283-314

  Korlipara, L V P ^a   Schapira, A H V ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; NITRIC OXIDE;

ANIMAL; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; GENETICS; HUMAN; MITOCHONDRION; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; HUMANS; MITOCHONDRIA; NITRIC OXIDE; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONIAN DISORDERS;

EID: 0036988063     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7742(02)53011-7     Document Type: Review

References (202)

1. Z.L. Alam S.E. Daniel A.J. Lees D.C. Marsden P. Jenner B. Halliwell A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J. Neurochem. 69 1997 1326 1329
2. J.K. Andersen J.Q. Mo D.G. Hom E.Y. Lee P. Harnish R.W. Hamill T.H. McNeill Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons J. Neurochem. 67 1996 2164 2171
3. M. Ankarcrona J.M. Dypbukt S. Orrenius P. Nicotera Calcineurin and mitochondrial function in glutamate-induced neuronal cell death FEBS Lett. 394 1996 321 324
4. Y. Aomi C.S. Chen K. Nakada S. Ito K. Isobe H. Murakami S.Y. Kuno M. Tawata R. Matsuoka H. Mizusawa J.I. Hayashij Cytoplasmic transfer of platelet mtDNA from elderly patients with Parkinson's disease to mtDNA-less HeLa cells restores complete mitochondrial respiratory function Biochem. Biophys. Res. Commun. 280 2001 265 273
5. A. Barrientos C.T. Moraes Titrating the effects of mitochondrial complex I impairment in the cell physiology J. Biol. Chem. 274 1999 16188 16197
6. N. Barroso Y. Campos R. Huertas J. Esteban J.A. Molina A. Alonso E. Gutierrez-Rivas J. Arenas Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease Clin. Chem. 39 1993 667 669
7. J.S. Beckman J.P. Crow Pathological implications of nitric oxide superoxide and peroxynitrite formation Biochem. Soc. Trans. 21 1993 330 334
8. A. Benazzouz T. Boraud P. Dubedat A. Boireau J.M. Stutzmann C. Gross Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study Eur. J. Pharmacol. 284 1995 299 307
9. G. Benzi D. Curti O. Pastoris E. Marzatico R.F. Villa F. Dagani Sequential damage in mitochondrial complexes by peroxidative stress Neurochem. Res. 16 1991 1295 1302
10. R. Betarbet T.B. Sherer G. MacKenzie M. Garcia-Osuna A.V. Panov J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
11. N.E. Bharucha L. Stokes B.S. Schoenberg C. Ward S. Ince J.G. Nutt R. Eldridge D.B. Calne N. Mantel R. Duvoisin A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors Neurology 36 1986 284 288
12. V.P. Bindokas R.J. Miller Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons J. Neurosci. 15 1995 6999 7011
13. A. Boireau P. Dubedat F. Bordier C. Peny J.M. Miquet G. Durand M. Meunier A. Doble Riluzole and experimental parkinsonism: Antagonism of MPTP-induced decrease in central dopamine levels in mice Neuroreport 5 1994 2657 2660
14. V. Bonifati E. Fabrizio N. Vanacore M. De Mari G. Meco Familial Parkinson's disease: a clinical genetic analysis Can. J Neurol. Sci. 22 1995 272 279
15. E. Brouillet M.E. Beal NMDA antagonists partially protect against MPTP neurotoxicity in mice Neuroreport 4 1993 387 390
16. M.D. Brown J.M. Shoffner Y.L. Kim A.S. Jun B.H. Graham M.E. Cabell D.S. Gurley D.C. Wallace Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients Am. J Med. Genet. 61 1996 283 289
17. D.S. Cassarino J.K. Parks W.D. Parker Jr. J.P. Bennett Jr. The parkinsonian neurotoxin MPP+ opens the mitochondrial membrane permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism Biochim. Biophy. Acta 1453 1999 49 62
18. B. Chance H. Sies A. Boveris Hyperoxide metabolism in mammalian organs Physiol. Rev. 59 1979 527 605
19. M.J.W. Cleeter J.M. Cooper A.H.V. Schapira Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement J. Neurochem. 58 1992 765 770
20. M.W. Cleeter J.M. Cooper A.H.V Schapira Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement J. Neurochem. 58 2 1992 786 789
21. M.W. Cleeter J.M. Cooper A.H. Schapira Nitric oxide enhances MPP+ inhibition of complex 1 FEBS Lett. 504 2001 50 52
22. M.W.J. Cleeter J.M. Cooper V.M. Darley-Usmar S. Moncada A.H.V. Schapira Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases FEBS Lett. 345 1994 50 54
23. K.J. Conn M.D. Ullman P.B. Eisenhauer R.E. Fine J.M. Wells Decreased expression of the NADH: Ubiquinone oxidoreductase (complex I) subunit 4 in 1-methyl4-phenyl tetrahydropyridine treated human neuroblastoma SH-SY5Y cells Neurosci. Lett. 306 2001 145 148
24. K.A. Conway J.D. Harper P.T. Lansbury Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320
25. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem. J. 341 1999 233 249
26. G.C. Davis A.C. Williams S.P. Markey M.H. Ebert E.D. Caine C.M. Reichert I.J. Kopin Chronic parkinsonism secondary to intravenous injection of meperidine analogues Psychiatry Res. 1 1979 249 254
27. V.L. Dawson T.M. Dawson E.D. London D.S. Bredt S.H. Snyder Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures Proc. Natl. Acad. Sci. 88 1991 6368 6371
28. V.L. Dawson V.M. Kizushi P.L. Huang S.H. Snyder T.M. Dawson Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice J. Neurosci. 16 1996 2463 2478
29. G. De Michele A. Filla G. Volpe V. de Marco A. Gogliettino G. Ambrosio R. Marconi A.E. Castellano G. Campanella Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy Mov. Disord. 11 1996 17 23
30. D.T. Dexter A.E. Holley W.D. Flitter T.E. Slater F.R. Wells S.E. Daniel A.J. Lees P. Jenner C.D. Marsden Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study Mov. Disord. 9 1994 92 97
31. D.T. Dexter P. Jenner A.H.V. Schapira C.D. Marsden Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group Ann. Neurol. 32 1992 S94 S100
32. D.T. Dexter J. Sian J. Rose J.G. Hindmarsh V.M. Mann J.M. Cooper E.R. Wells S.E. Daniel A.J. Lees A.H. Schapira P. Jenner C.D. Marsden Indices of oxidative stress and mitochondria) function in individuals with incidental Lewy body disease Ann. Neural. 35 1994 38 44
33. D.T. Dexter F.R. Wells A.J. Lees F. Agid Y. Agid P. Jenner C.D. Marsden Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease J. Neurochem. 52 1989 1830 1836
34. B. Dipasquale A.M. Marini R.J. Youle Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons Biochem. Biophys. Res. Commun. 181 1991 1442 1448
35. J.A. Dykens Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca(+) and Na(+): Implications for neurodegeneration J. Neurochem. 63 1994 584 591
36. B.I. Giasson J.E. Duda S.M. Quinn B. Zhang J.Q. Trojanowski V.M.-Y. Lee Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein Neuron 34 2002 521 533
37. B.I. Giasson J.E. Duda I.V.J. Murray Q. Chen J.M. Souza H.I. Hurtig H. Ischiropoulos J.Q. Trojanowski V.M.-Y. Lee Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
38. + increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells Brain Res. 935 2002 32 39
39. P.F. Good A. Hsu P. Werner D.P. Perl C.W. Olanow Protein nitration in Parkinson's disease J. Neuropathol. Exp. Neural. 57 1998 338 342
40. J.M. Gorell C.C. Johnson B.A. Rybicki E.L. Peterson R.J. Richardson The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 1998 1346 1350
41. E.M. Grasbon-Frodl S. Kosel M. Sprinzl U. von Eitzen P. Mehraein M.B. Graeber Two novel point mutations of mitochondria) tRNA genes in histologically confirmed Parkinson disease Neurogmetics 2 1999 121 127
42. M. Gu J.M. Cooper J.W. Taanman A.H. Schapira Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease Ann. Neural. 44 1998 177 186
43. M. Gu M.T. Gash J.M. Cooper G.K. Wenning S.E. Daniel N.P. Quinn C.D. Marsden A.H. Schapira Mitochondrial respiratory chain function in multiple system atrophy Mov. Disord. 12 1997 418 422
44. M. Gu M.T. Gash V.M. Mann F. Javoy-Agid J.M. Cooper A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neural. 39 1996 385 389
45. R.H. Haas F. Nasirian K. Nakano D. Ward M. Pay R. Hill C.W. Shults Low platelet mitochondria) complex I and complex II/III activity in early untreated Parkinson's disease Ann. Neural. 37 1995 714 722
46. B. Halliwell J. Gutteridge Oxygen radicals and the nervous system Trends Neurosci. 8 1985 22 29
47. P. Hantraye E. Brouillet R. Ferrante S. Palfi R. Dolan R.T. Matthews M.F. Beal Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat. Med. 2 9 1996 1017 1021
48. P. Hantraye E. Brouillet R. Ferrante S. Palfi R. Dolan R.T. Matthews M.F. Beal Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat. Med. 2 1996 1017 1021
49. A. Hartley J.M. Stone C. Heron J.M. Cooper A.H. Schapira Complex I inhibitors induce dose-dependent apoptosis in PC 12 cells: Relevance to Parkinson's disease J. Neurochem. 63 5 1994 1987 1990
50. A. Hartley J.M. Stone C. Heron J.M. Cooper A.H.V Schapira Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease J. Neurochem. 63 1994 1987 1990
51. A. Hartmann S. Hunot P.P. Michel M. Murielm S. Vyas B.A. Faucheux A. Mouatt-Progent H. Turnel A. Srinivasan M. Ruberg G.I. Evan Y. Agid E.C. Hirsch Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease Proc. Natl. Acad. Sci. 97 2000 2875 2880
52. A. Hartmann J.-D. Troadec S. Hunot K. Kikly A. Faucheux A. Mouatt-Prigent M. Ruberg Y. Agid E.C. Hirsch Caspase-8 is an effector in apoptotic death in dopaminergic neurons in parkinson's disease, but pathway inhibition results in neuronal necrosis J. Neurosci. 21 2001 2247 2255
53. L. Hassouna H. Wickert M. Zimmermann F. Gillardon Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice Neurosci. Lett. 204 1996 85 88
54. N. Hattori H. Yoshino M. Tanaka H. Suzuki Y. Mizuno Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease Genomics 49 1988 52 58
55. Y. He T. Lee S.K. Leong 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra Brain Res. 858 2000 163 166
56. L. Hillered L. Ernster Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals J. Cereb. Blood Flow Metab. 3 1983 207 214
57. E.C. Hirsch J.-P. Brandel P. Galle F. Javoy-Agid Y. Agid Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: An X-ray microanalysis J. Neurochem. 56 1991 446 451
58. O. Hornykiewicz Parkinson's disease and its chemotherapy Biochem. Pharmacol. 24 1975 1061 1065
59. S. Ikebe M. Tanaka T. Ozawa Point mutations of mitochondrial genome in Parkinson's disease Brain Res. Mol. Brain Res. 28 1995 281 295
60. S. Ikebe M. Tanaka K. Ohno W. Sato K. Hattori T. Kondo Y. Mizuno T. Ozawa Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence Biochem. Biophys. Res. Commun. 170 1990 1044 1048
61. H. Ishiguro K. Yasuda N. Ishii K. Ihara T. Ohkubo M. Hiyoshi K. Ono N. Senoo-Matsuda O. Shinohara E. Yosshii M. Murakami P.S. Hartman M. Tsuda Enhancement of oxidative damage to cultured cells and Caenorhabditis elegans by mitochondrial electron transport inhibitors IUBMB Life 51 2001 263 268
62. B. Janetzky S. Hauck M.B. Youdim P. Riederer K. Jellinger E. Pantucek R. Zochling K.W. Boissl H. Reichmann Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease Neurosci. Lett. 169 1994 126 128
63. J. Jankovic C. Hunter A double-blind, placebo controlled and longitudinal study of riluzole in early Parkinson's disease Parkinsonism Relat. Disord. 8 2002 271 276
64. K. Jellinger E. Kienzl G. Rumpelmair E. Riederer H. Stachelberger D. Ben-Shacher M.B.H. Youdin Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis J. Neurochem. 59 1992 1168 1171
65. S.P. Kantrow C.A. Piantadosi Release of cytochrome c from liver mitochondria during permeability transition Biochem. Biophys. Res. Commun. 232 1997 669 671
66. R.M. Kapsa M.J. Jean-Francois P. Lertrit S. Weng N. Siregar J. Ojaimi G. Donman C. Masters E. Byrne Mitochondrial DNA polymorphism in substantia nigra J. Neurol. Sci. 144 1996 204 211
67. J.F.R. Kerr A.H. Wyllie A.R. Currie Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics Br. J. Cancer 26 1972 239 257
68. S.C. Kirchner S.E. Hallagan F.M. Farin J. Dilley P. Costa-Mallen T. Smith-Weller G.M. Franklin P.D. Swanson H. Checkoway Mitochondrial NDI sequence analysis and association of the T4216C mutation with Parkinson's disease Neurotoxicology 21 2000 441 445
69. S.J. Kish C. Bergeron A. Rajput S. Dozic F. Mastrogiacomo L.J. Chang J.M. Wilson L.M. DiStefano J.N. Nobrega Brain cytochrome oxidase in Alzheimer's disease J. Neurochem. 59 1992 776 779
70. J. Kitada S. Asakawa N. Hattori H. Matsumine Y. Yamamura S. Minoshima M. Yokochi Y. Mizuno N. Shimizu Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
71. C. Knott G. Stern G.P. Wilkin Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1 and cyclooxygenases-1 and -2 Mol. Cell. Neurosci. 16 2000 720 739
72. T. Kobayashi H. Matsumine S. Matuda Y. Mizuno Association between the gene encoding the E2 subunit of the alpha-ketoglutarate dehydrogenase complex and Parkinson's disease Ann. Neurol. 43 1998 120 123
73. S. Kosel R. Egensperger U. von Eitzen P. Mehraein M.B. Graeber On the question of apoptosis in the parkinsonian substantia nigra Acta Neuropathol. 93 1997 105 108
74. S. Kosel E.M. Grasbon-Frodl U. Mautsch R. Egensperger U. von Eitzen D. Frishman S. Hofmann K.D. Gerbitz P. Mehraein M.B. Graeber Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease Neurogenetics 1 1998 197 204
75. S. Kosel C.B. Lucking R. Egensperger P. Mehraein M.B. Graeber Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism J. Neurosci. Res. 44 1996 170 183
76. N.W. Kowall P. Hantraye P. Brouillet M.F. Beal A.C. McKee R.J. Ferrante MPTP induces alpha synuclein aggregation in the substantia nigra of baboons Neuroreport. 11 2000 211 213
77. D. Krige M.T. Carroll J.M. Cooper C.D. Marsden A.H. Schapira Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group Ann. Neurol. 32 1992 782 788
78. J.W. Langston P. Ballard Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine: implications for treatment and the pathophysiology of Parkinson's Disease Can J. Neural. Sci. 11 1984 160 165
79. J.W. Langston P. Ballard J.W. Tetrud I. Irwin Chronic Parkinsonism in humans due to a product of meperidine analog synthesis Science 219 1983 979 980
80. J.W. Langston L.S. Foro C.S. Rebert I. Irwin Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey Brain Res. 292 2 1984 390 394
81. M.J. LaVoie T.J. Hastings Peroxynitrite- and nitrite-induced oxidation of dopamine. Implications for nitric oxide in dopaminergic cell loss J. Neurochem. 73 1999 2546 2554
82. H.J. Lee S.Y. Shin C. Choi Y.H. Lee S.J. Lee Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors J. Biol. Chem. 277 7 2002 5411 5417
83. E. Leroy R. Boyer G. Auburger B. Leube G. Ulm E. Mezey G. Harta M.J. Brownstein S. Jonnalagada T. Chernova A. Dehejia C. Lavedan T. Gasser P.J. Steinbach K.D. Wilkinson M.H. Polymeropoulos The ubiquitin pathway in Parkinson's disease Nature 395 1998 451 452
84. P. Lestienne L. Nelson P. Riederer H. Reichmann K. Jellinger Mitochondrial DNA in postmortem brain from patients with Parkinson's disease J. Neurochem. 56 1991 1819
85. P. Lestienne J. Nelson E. Riederer K. Jellinger H. Reichmann Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect J. Neurochem. 55 1990 1810 1812
86. F. Li A. Srinivasan Y. Wang R.C. Armstrong K.J. Tomaselli L.C. Fritz Cell-specific induction of apoptosis by microinjection of cytochrome c . Bcl-xL has activity independent of cytochrome c release J. Biol. Chem. 272 1997 30299 30305
87. G.T. Liberatore V. Jackson-Lewis S. Vukosavic A.S. Mandir M. Vila W.G. McAuliffe V.L. Dawson T.M. Dawson S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Nat. Med. 5 12 1999 1403 1408
88. J. Liptrot D. Holdup O. Phillipson 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in rat brain J. Neurochem. 61 1993 2199 2206
89. X. Liu C.N. Kim J. Yang R. Jemmerson X. Wang Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 1996 147 157
90. C.B. Lucking S. Kosel P. Mehraein M.B. Graeber Absence of the mitochondrial A7237T mutation in Parkinson's disease Biochem. Biophys. Res. Commun. 211 1995 700 704
91. L. Lyras B.Y. Zeng G. McKenzie R.K. Pearce B. Halliwell P. Jenner Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeys J. Neural Transm. 109 2002 53 67
92. Y. Makino S. Ohta O. Tachikawa M. Hirobe Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: Compounds related to Parkinson's disease Life Sci. 43 1988 373 378
93. V.M. Mann J.M. Cooper S.E. Daniel P. Jenner C.D. Marsden A.H.V Schapira Complex I, iron and ferritin in Parkinson's disease substantia nigra Ann. Neurol. 36 1994 876 881
94. V.M. Mann J.M. Cooper D. Krige S.E. Daniel A.H. Schapira C.D. Marsden Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 1992 333 342
95. K. Marder M.X. Tang H. Mejia B. Alfaro L. Cote E. Louis J. Groves R. Mayeux Risk of Parkinson's disease among first-degree relatives: A community-based study Neurology 47 1996 155 160
96. M.A. Martin J.A. Molina F.J. Jimenez Jimenez J. Benito-Leon M. Orti-Pareja Y. Campos J. Arenas Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Grupo-Centro de Trastornos del Movimiento Neurology 46 1996 1343 1346
97. R.J. Marttila J. Kaprio M. Koskenvuo U.K. Rinne Parkinson's disease in a nationwide twin cohort Neurology 38 1988 1217 1219
98. R.J. Marttila H. Lorentz U.K. Rinne Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus J. Neurol. Sci. 86 1988 321 331
99. W. Maruyama P. Dostert M. Naoi Dopamine-derived 1-methyl-6,7dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: In vivo and in vitro studies J. Neurochem. 64 1995 2635 2643
100. W. Maruyama P. Dostert K. Matuara M. Naoi N -methyl(R)salsolinol produces hydroxyl radicals: Involvement to neurotoxicity Free Radic. Biol. Med. 19 1995 67 75
101. E. Masliah E. Rockenstein I. Veinbergs M. Mallory M. Hashimoto A. Takeda Y. Sagara A. Sisk L. Mucke Dopaminergic loss and inclusion body formation in α-synuclein mice. Implications for neurodegenerative diseases Science 287 2000 1266 1269
102. K. Matsuura H. Kabuto H. Makino N. Ogawa Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice Neurosci. Lett. 230 1997 191 196
103. K. Matsuura H. Makino N. Ogawa Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine Exp. Neural. 146 1997 526 535
104. R.T. Matthews M.F. Beal J. Fallon K. Fedorchak P.L. Huang M.C. Fishman B.T. Hyman MPP+ induced substantia nigra degeneration is attenuated in nNOS knockout mice Neurobiol. Dis. 4 1997 114 121
105. U. Mayr-Wohlfart G. Rodel A. Henneberg Mitochondrial tRNA(Gln) and tRNA(Thr) gene variants in Parkinson's disease Eur. J. Med. Res. 2 1997 111 113
106. K.S. McNaught P. Jenner Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci. Lett. 297 2001 191 194
107. K.S. McNaught U. Thull P.A. Carrupt C. Altomare S. Cellamare A. Carotti B. Testa P. Jenner C.D. Marsden Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Biochem. Pharmacol. 50 1995 1903 1911
108. I.J. Mitchell S. Lawson B. Moser S.M. Laidlaw A.J. Cooper G. Walkinshaw C.M. Waters Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat Neuroscience 63 1994 1 5
109. K. Miyako T. Irie T. Muta S. Umeda Y. Kai T. Fujiwara K. Takeshige D. Kang 1-Methyl-4-phenylpyridinium ion (MPP+) selectively inhibits the replication of mitochondrial DNA Eur.J Biochem. 259 1999 412 418
110. Y. Mizuno S. Matuda H. Yoshino H. Mori N. Hattori S. Ikebe An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease Ann. Neurol. 35 1994 200 210
111. Y. Mizuno T. Saitoh N. Sone Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion Biochem. Biophys. Res. Commun. 143 1987 971 976
112. Y. Mizuno K. Suzuki S. Ohta Post-mortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease J. Neurol. Sci. 96 1990 49 57
113. H. Mochizuki K. Goto H. Mori Y. Mizuno Histochemical detection of apoptosis in Parkinson's disease J. Neurol. Sci. 137 1996 120 123
114. M. Mogi M. Harada T. Kondo Y. Mizuno H. Narabayashi P. Riederer T. Nagatsu Bcl-2 protein is increased in the brain from parkinsonian patients Neurosci. Lett. 215 1996 137 139
115. N. Morikawa M. Naoi W. Maruyama S. Ohta Y. Kotake H. Kawai T. Niwa P. Dostert Y. Mizuno Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes J. Neural. Transm. 105 1998 677 688
116. T. Nagatsu Isoquinoline neurotoxins in the brain and Parkinson's disease Neurosci. Res. 29 1997 99 111
117. T. Nagatsu M. Yoshida An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions Neurosci. Lett. 87 1988 178 182
118. M. Naoi W. Maruyama P. Dostert Y. Hashizume D. Nakahara T. Takahashi M. Ota Dopamine-derived endogenous 1(R),2( N )-dimethyl-6,7-dihydroxy-1,2,3,4 tetrahydroisoquinoline, N -methyl-(R)-salsolinol, induced parkinsonism in rat: Biochemical, pathological and behavioural studies Brain Res. 709 1996 285 295
119. M. Naoi S. Matsuura H. Parvez T. Takahashi Y. Hirata M. Minami T. Nagatsu Oxidation of N -methyl-1,2,3,4-tetrahydroisoquinoline into the N -methyl-isoquinolinium ion by monoamine oxidase J. Neurochem. 52 1989 653 655
120. D.D. Newmeyer D.M. Farschon J.C. Reed Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria Cell 79 1994 353 364
121. W.J. Nicklas I. Vyas R.E. Heikkila Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4 phenyl-1,2,5,6-tetrahydropyridine Life Sci. 36 1985 2503 2508
122. A.L. Nieminen T.G. Petrie J.J. Lemasters W.R Selman Cyclosporin A delays mitochondrial depolarization induced by N -methyl- d -aspartate in cortical neurons: evidence of the mitochondrial permeability transition Neuroscience 75 1996 993 997
123. +) and tetrahydroisoquinoline derivatives on dopaminergic neurons in ventral mesencephalic-striatal co-culture Neurodegeneration 3 1994 33 42
124. T. Niwa N. Takeda A. Tatematsu S. Matsuura M. Yoshida T. Nagatsu Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry J. Chromatogr 452 1988 85 91
125. T. Niwa H. Yoshizumi A. Tatematsu S. Matsuura T. Nagatsu Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods J. Chromatogr. 493 1989 347 352
126. N. Ogawa Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain Brain Res. 733 1996 101 104
127. C.W. Olanow Oxidation reactions in Parkinson's disease Neurology 40 1990 32 37
128. T. Ozawa M. Tanaka H. Ino K. Ohno T. Sano Y. Wada M. Yoneda Y. Tanno T. Miyatake T. Tanaka Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease Biochem. Biophys. Res. Commun. 176 1991 938 946
129. M.A. Packer J.L. Scarlett S.W. Martin M.P. Murphy Induction of the mitochondrial permeability transition by peroxynitrite Biochem. Soc. Trans. 25 1997 909 914
130. W.D. Parker S.J. Boyson J.K. Parks Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann. Neural. 26 1989 719 723
131. H. Payami K. Larsen S. Bernard J. Nutt Increased risk of Parkinson's disease in parents and siblings of patients Ann. Neurol. 36 1994 659 661
132. A.M. Penn T. Roberts J. Hodder P.S. Allen G. Zhu W.R. Martin Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle Neurology 45 1995 2097 2099
133. T.L. Perry D.V. Godin S. Hansen Parkinson's disease: A disorder due to nigral glutathione deficiency Neurosci. Lett. 33 1982 305 310
134. P. Piccini D.J. Burn R. Ceravolo D. Maraganore D.J. Brooks The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins Ann. Neurol. 45 1999 577 582
135. M.H. Polymeropoulos C. Lavedan E. Leroy S.E. Ide A. Dehejia A. Dutra B. Pike H. Root J. Rubenstein R. Boyer E.S. Stenroos S. Chandrasekharappa A. Athanassiadou T. Papapetropoulos W.G. Johnson A.M. Lazzarini R.C. Duvoisin G. Di Iorio L. Golbe R.L. Nussbaum Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
136. S. Przedborski V. Jackson-Lewis U. Muthane H. Jiang M. Ferreira A.B. Naini S. Fahn Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity Ann. Neurol. 34 1993 715 723
137. G.A. Quereshi S. Baig I. Bednar P. Sodersten G. Forsberg A. Siden Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease Neuroreport 6 1995 1642 1646
138. A.H. Rajput R.J. Uitti W. Stern W. Laverty Early onset Parkinson's disease in Saskatchewan—environmental considerations for etiology Can. J. Neurol. Sci. 13 1986 312 316
139. R.R. Ramsay M.J. Krueger S.K. Youngster M.R. Gluck J.E. Casida T.P. Singer Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase J. Neurochem. 56 4 1991 180 190
140. R.R. Ramsay J.I. Salach J. Dadgar T.P. Singer Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism Biochem. Biophys. Res. Commun. 135 1986 269 275
141. M. Rana I. de Coo F. Diaz H. Smeets C.T. Moraes An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production Ann. Neurol. 48 2000 774 781
142. H. Saggu J. Cooksey D. Dexter E.R. Wells A. Lees R. Jenner C.D. Marsden A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra J. Neurochem. 53 1989 692 697
143. J. Sanchez-Ramos E. Overik B.N. Ames A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease Neurodegeneration 3 1994 197 204
144. H. Saybasili M. Yuksel G. Haklar A.S. Yalcin Effect of mitochondrial electron transport chain inhibitors on superoxide radical generation in rat hippocampal and striatal slices Antioxid. Redox Signal. 3 2001 1099 1104
145. A.H. Schapira Evidence for mitochondrial dysfunction in Parkinson's disease — a critical appraisal Mov. Disord. 9 1994 125 138
146. A.H. Schapira J.M. Cooper D. Dexter J.B. Clark P. Jenner C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease J. Neurochem. 54 1990 823 827
147. A.H. Schapira J.M. Cooper D. Dexter P. Jenner J.B. Clark C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269
148. 1 reductase (complex I) deficiency in Parkinson's disease J. Neurochem. 55 1990 2142 2145
149. A.F. Schinder E.C. Olson N.C. Spitzer M. Montal Mitochondrial dysfunction is a primary event in glutamate neurotoxicity J. Neurosci. 16 1996 6125 6133
150. N.M. Schnopp S. Kosel R. Egensperger M.B. Graeber Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain Clin. Neuropathol. 15 1996 348 352
151. J.B. Schulz R.T. Matthews M.M. Muqit S.E. Browne M.F. Beal Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice J. Neurochem. 64 1995 936 939
152. T.A. Seaton J.M. Cooper A.H. Schapira Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins Brain Res 809 1998 12 17
153. T.A. Seaton J.M. Cooper A.H. Schapira Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors Brain Res. 777 1997 110 118
154. J.K. Shergill R. Cammack C.E. Cooper J.M. Cooper V.M. Mann A.H. Schapira Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease Biochem. Biophys. Res. Commun. 228 1996 298 305
155. S. Shimoda-Matsubayashi H. Matsumine T. Kobayashi Y. Nakagawa-Hattori Y. Shimizu Y. Mizuno Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease Biochem. Biophys. Res. Commun. 226 1996 561 565
156. J.M. Shoffner M.D. Brown A. Torroni M.T. Lott M.E. Cabell S.S. Mirra M.E. Beal C.C. Yang M. Gearing R. Salvo R.L. Watts J.L. Juncos L.A. Hansen B.J. Crain M. Fayad C.L. Reckord D.C. Wallace Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients Genomics 17 1993 171 184
157. C.W. Shults R.H. Haas M.F. Beal A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease Biofactors 9 1999 267 272
158. J. Sian D.T. Dexter A.J. Lees S. Daniel Y. Agid F. Javoy-Agid P. Jenner C.D. Marsden Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann. Neurol. 36 1994 348 355
159. G. Siciliano M. Mancuso R. Ceravolo V. Lombardi A. Iudice U. Bonuccelli Mitochondrial DNA rearrangements in young onset parkinsonism: Two case reports J. Neurol. Neurosurg. Psychiatry 71 2001 685 687
160. D.K. Simon R. Mayeux K. Marder N.W. Kowall M.E. Beal D.R. Johns Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease Neurology 54 2000 703 709
161. D.K. Simon S.M. Pulst J.P. Sutton S.E. Browne M.E. Beal D.R. Johns Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation Neurology 53 1999 1787 1793
162. T.P. Singer R.R. Ramsay K. McKeown A. Trevor N.E. Castagnoli Jr. Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Toxicology 49 1 1988 17 23
163. A.F. Slater C.S. Nobel S. Orrenius The role of intracellular oxidants in apoptosis Biochim. Biophys. Acta 1271 1995 59 62
164. E. Sofic W. Paulus K. Jellinger P. Riederer M.B. Youdim Selective increase of iron in substantia nigra zona compacta of parkinsonian brains J. Neurochem. 56 1991 978 982
165. E. Sofic K.W. Lange K. Jellinger P. Riederer Reduced and oxidised glutathione in the substantia nigra of patients with Parkinson's disease Neurosci. Lett. 142 1992 128 130
166. M. Spillantini M.L. Schmidt V.M.Y. Lee J.Q. Trojanowski R. Jakes M. Goedert α-Synuclein in Lewy bodies Nature 388 1997 839 840
167. L. Stefanis R.E. Burke L.A. Greene Apoptosis in neurodegenerative disorders Curr Opin. Neurol. 10 1997 299 305
168. E. Storey B.T. Hyman B. Jenkins E. Brouillet J.M. Miller B.R. Rosen M.F. Beal 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism J. Neurochem. 58 1992 1975 1978
169. S.A. Susin H.K. Lorenzo N. Zamzami I. Marzo B.E. Snow G.M. Brothers J. Mangion E. Jacotot P. Costantini M. Loeffler N. Larochette D.R. Goodlett R. Aebersold D.P. Siderovski J.M. Penninger G. Kroemer Molecular characterization of mitochondrial apoptosis-inducing factor Nature 397 1999 441 446
170. K. Suzuki Y. Mizuno M. Yoshida Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline Neurosci. Lett. 86 1988 105 108
171. K. Suzuki Y. Mizuno Y. Yamauchi T. Nagatsu Y. Mitsuo Selective inhibition of complex I by N -methylisoquinolinium ion and N -methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain J. Neurol. Sci. 109 1992 219 223
172. R.H. Swerdlow J.K. Parks S.W. Miller J.B. Tuttle P.A. Trimmer J.P. Sheehan J.P. Bennett Jr. R.E. Davis W.D. Parker Jr. Origin and functional consequences of the complex I defect in Parkinson's disease Ann. Neurol. 40 1996 663 671
173. K. Takeshige S. Minakami NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles Biochem. J. 180 1979 129 135
174. N.A. Tatton S.J. Kish In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience 77 1997 1037 1048
175. D.J. Taylor D. Krige P.R. Barnes G.J. Kemp M.T. Carroll V.M. Mann J.M. Cooper C.D. Marsden A.H. Schapira A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease J. Neurol. Sci. 125 1994 77 81
176. P.K. Thomas J.M. Cooper R.H.M. King J.M. Workman A.H.V. Schapira M.A. Goss-Sampson D.P.R. Muller Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances in mitochondrial function J. Anat. 183 1993 451 461
177. D. Thyagarajan S. Bressman C. Bruno S. Przedborski S. Shanske T. Lynch S. Fahn S. DiMauro A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy Ann. Neurol. 48 2000 730 736
178. S. Toffa G.M. Kunikowska B.-Y. Zeng P. Jenner C.D. Marsden Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration J. Neural Transm. 104 1997 60 75
179. M.M. Tompkins E.J. Basgall E. Zamrini W.D. Hill Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons Am. J. Pathol. 150 1997 119 131
180. H. Turmel A. Hartmann K. Parain A. Douhou A. Srinivasan Y. Agid E.C. Hirsch Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)treated mice Mov. Disord. 16 2001 185 189
181. P. Vieregge I. Heberlein Increased risk of Parkinson's disease in relatives of patients Ann. Neurol. 37 1995 685
182. P. Vieregge K.A. Schiffke H.J. Friedrich B. Muller H.P. Ludin Parkinson's disease in twins Neurology 42 1992 1453 1461
183. M. Vila V. Jackson-Lewis V. Vukosavic R. Djaldetti G. Liberatore D. Offen S.J. Korsmeyer S. Przedborski Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-tetrahydropyridine mouse model of Parkinson's disease Proc. Natl. Acad. Sci. 98 2001 2837 2842
184. M. Vila S. Vukosavic V. Jackson-Lewis M. Neystat M. Jakowec S. Przedborski α-Synuclein upregulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTR J. Neurochem. 74 2 2000 721 729
185. E.J. Vingerhoets B.J. Snow J.W. Tetrud J.W. Langston M. Schulzer D.B. Calne Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions Ann. Neurol. 36 1994 765 770
186. V. Viswanath W. Yongqin K. Boonplueang S. Chen F.E. Stevenson F. Yantiri L. Yang M.E. Beal J.K. Anderson Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease J. Neurosci. 21 2001 9519 9528
187. C. Vives-Bauza A.L. Andreu G. Manfredi M.E. Beal B. Janetzky T.H. Gruenewald M.T. Lin Sequence analysis of the entire mitochondrial genome in Parkinson's disease Biochem. Biophys. Res. Commun. 290 2002 1593 1601
188. J.S. Wadia R.M.E. Chalmers-Redman W.J.H. Ju G.W. Carlile J.L. Phillips A.D. Fraser W.G. Tatton Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: Time course and modification by (−)-deprenyl J. Neurosci. 18 1998 932 947
189. G. Walkinshaw C.M. Waters Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease J. Clin. Invest. 95 1995 2458 2464
190. G. Walkinshaw C.M. Waters Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis Neuroscience 63 1994 975 987
191. R.J. White I.J. Reynolds Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure J. Neurosci. 16 1996 5688 5697
192. G.F. Wooten L.J. Currie J.P. Bennett M.B. Harrison J.M. Trugman W.D. Parker Jr. Maternal inheritance in Parkinson's disease Ann. Neurol. 41 1997 265 268
193. + toxicity in nigral dopaminergic neurons Neuroreport 7 1996 921 923
194. A. Yoritaka N. Hattori H. Mori K. Kato Y. Mizuno An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease J. Neural. Sci. 148 1997 181 186
195. E. Yoshida K. Mokuno S. Aoki A. Takahashi S. Riku T. Murayama T. Yanagi K. Kato Cerebrospinal fluid of superoxide dismutases in neurological diseases detected by sensitive enzyme immunoassays J. Neurol. Sci. 124 1994 25 31
196. M. Yoshida T. Niwa T. Nagatsu Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioural and biochemical changes Neurosci. Lett. 119 1990 109 113
197. H. Yoshino Y. Nakagawa-Hattori T. Kondo Y. Mizuno Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease J. Neural Transm. Park. Dis. Dement. Sect. 4 1992 27 34
198. G.D. Zeevalk W.J. Nicklas Chemically induced hypoglycaemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina J. Pharmacol. Exp. Ther. 253 1990 1285 1292
199. G.D. Zeevalk W.J. Nicklas Mechanisms underlying initiation of excitoxicity associated with metabolic inhibition J. Pharmacol. Exp. Ther. 257 1991 870 878
200. Y. Zhang O. Marcillat C. Giulivi I. Ernster K.J. Davies The oxidative inactivation of mitochondrial electron transport chain components and ATP J. Biol. Chem. 265 1990 16330 16336
201. I. Ziv E. Melamed N. Nardi D. Luria A. Achiron D. Offen A. BarziW Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenetic mechanism in Parkinson's disease Neurosci. Lett. 170 1994 136 140
202. A. Zuddas G. Oberto E. Vaglini E. Fascetti F. Fornai G.U. Corsini MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates J. Neurochem. 59 1992 733 739